Conditions: Esophageal Cancer
Intervention Type: Other
Intervention Name: pharmacological study
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Other" intervention "pharmacological study" on "Esophageal Cancer".
-
Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (VORINOSTAT)] With Irinotecan, 5-Fluorouracil (5-FU) and Leucovorin (FOLFIRI) for Advanced Upper Gastrointestinal Cancers
NCTID: NCT00537121
-
A Pharmacogenetic-Based Phase I Trial of Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in Patients With Advanced Gastrointestinal Cancer
NCTID: NCT00654160
-
Phase I Study of Sunitinib With FOLFIRI (Irinotecan, 5-Fluorouracil and Leucovorin) for Advanced Gastroesophageal Cancers
NCTID: NCT00524186
-
A Phase I Study of Vorinostat in Combination With Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
NCTID: NCT01249443